Catyalyst Pharma (CPRX) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.42 +0.06%
Revenue Growth %: +5.9%
Financial Fact:
Loss per share - basic and diluted: -0.05
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +5.9%
Financial Fact:
Loss per share - basic and diluted: -0.05
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q1 EPS ex-items of ($0.06), in-line with the analyst estimate of ($0.06).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- Morgan Stanley raises dividend 15% and approves $20B buyback program
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
